Most Read Articles
6 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
4 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 5 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 2 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.

Patients with retinal artery occlusion at risk of acute stroke

24 Sep 2019

Acute cerebral ischaemia is detected by magnetic resonance imaging (MRI) in 30 percent of patients with acute central retinal artery occlusion (CRAO) and 25 percent of those with acute branch retinal artery occlusion (BRAO), results of a systematic review and meta-analysis have shown.

“Such high rates support a care pathway of prompt referral of such patients for neurological evaluation and brain imaging,” the investigators said.

A systematic search was performed using PubMed, Medline and Cochrane Library for studies reporting the incidence of acute cerebral ischaemia, detected by MRI, within 7 days from diagnosis of acute CRAO, BRAO and transient monocular vision loss (TMVL) up to January 2019. Random effects model was used to carry out the meta-analysis.

The primary outcome measure was the pooled estimate of incidence of acute cerebral ischaemia in CRAO, BRAO and TMVL cohorts including both neurologically symptomatic and asymptomatic patients, while the secondary outcome measure was the pooled estimate of incidence of asymptomatic acute cerebral ischaemia.

The pooled proportion of acute cerebral ischaemia was 0.30 (95 percent CI, 0.24–0.36) and 0.25 (0.16–0.37) in the CRAO and BRAO cohort, respectively. No statistical heterogeneity was seen in the studies. The TMVL cohort had an 11.8-percent rate of acute cerebral ischaemia.

Moreover, the pooled proportion of asymptomatic acute cerebral ischaemia was 0.22 (0.16–0.28) in the CRAO cohort, 0.29 (0.20–0.41) in the BRAO cohort and 0.08 (0.05–0.15) in the TMVL cohort, without statistical heterogeneity.

Editor's Recommendations
Most Read Articles
6 days ago
Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.
4 days ago
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
Elvira Manzano, 5 days ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Jairia Dela Cruz, 2 days ago
Many patients with nonvalvular atrial fibrillation (NVAF) in Thailand use anticoagulants, but the uptake of nonvitamin-K oral anticoagulants remains suboptimal despite showing an upward trend, according to data from the COOL-AF registry presented at the European Society of Cardioloy (ESC) Asia Congress 2019 with APSC and AFC.